Literature DB >> 7477615

Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol).

C Combe1, D Morel, V de Précigout, V Blanchetier, J L Bouchet, L Potaux, A Fournier, M Aparicio.   

Abstract

Phosphorus (Pi) retention linked to chronic renal failure (CRF) favors secondary hyperparathyroidism (HPT). Reduction of Pi and protein intake has been shown to prevent the development of HPT in CRF. The aim of the present study was to assess in patients with advanced CRF the long-term effects on phosphate and calcium metabolism of a low-Pi (5-7 mg/kg/day), low-protein (0.4 g/kg/day) diet providing 300 mg/day calcium (Ca) and supplemented with amino acids and ketoacids, Ca carbonate (400-800 mg/day) and vitamin D2 (1,000 IU/day). Twenty-nine patients with advanced CRF (glomerular filtration rate (GFR) 13.7 +/- 4.5 ml/min) were selected for the study, on the basis of a follow-up of a least 2 years and a satisfactory compliance to the prescribed diet. At the start of the study, biological evidence of HPT was present with increased plasma PTH concentration (144 +/- 95 pg/ml), increased plasma Pi (1.57 +/- 0.33 mmol/l), an increase in alkaline phosphatase activity and plasma osteocalcin concentration. Plasma PTH concentration was positively correlated with plasma Pi and inversely with plasma Ca concentrations and GFR. Pi and protein restriction induced a significant correction of HPT within 3 months after starting the diet. After 2 years of diet, despite the diminution of GFR (11.1 +/- 3.7 ml/min, p < 0.0001), plasma PTH was still lower than at the start of the diet (88 +/- 57 pg/ml, p < 0.01), as was plasma Pi (1.32 +/- 0.24 mmol/l, p < 0.001), total plasma Ca being higher (p < 0.01). Plasma PTH levels were correlated only to plasma Ca concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477615     DOI: 10.1159/000188606

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

Review 1.  Recent Advances in the Role of Diet in Bone and Mineral Disorders in Chronic Kidney Disease.

Authors:  Orlando M Gutiérrez
Journal:  Curr Osteoporos Rep       Date:  2021-11-03       Impact factor: 5.096

2.  Diets for patients with chronic kidney disease, should we reconsider?

Authors:  William E Mitch; Giuseppe Remuzzi
Journal:  BMC Nephrol       Date:  2016-07-11       Impact factor: 2.388

3.  Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

Authors:  Kenneth R Phelps
Journal:  Nutrients       Date:  2017-04-26       Impact factor: 5.717

Review 4.  Energy restriction in renal protection.

Authors:  Si-Yang Wang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Br J Nutr       Date:  2018-11       Impact factor: 3.718

Review 5.  Strategies for Phosphate Control in Patients With CKD.

Authors:  Fellype Carvalho Barreto; Daniela Veit Barreto; Ziad A Massy; Tilman B Drüeke
Journal:  Kidney Int Rep       Date:  2019-06-20

6.  Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial.

Authors:  Wan-Chuan Tsai; Hon-Yen Wu; Yen-Ling Chiu; Ju-Yeh Yang; Mei-Fen Pai; Yong-Ru Wu; Wan-Yu Lin; Kuan-Yu Hung; Kuo-Liong Chien; Shih-Ping Hsu; Yu-Sen Peng
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

7.  Chemical evidence for the tradeoff-in-the-nephron hypothesis to explain secondary hyperparathyroidism.

Authors:  Kenneth R Phelps; Darren E Gemoets; Peter M May
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

Review 8.  The Influence of Dietary Interventions on Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors:  Jacek Rysz; Beata Franczyk; Robert Rokicki; Anna Gluba-Brzózka
Journal:  Nutrients       Date:  2021-06-16       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.